1. Inhibitory signaling sustains a distinct early memory CD8 + T cell precursor that is resistant to DNA damage
- Author
-
Kristen E. Pauken, Zhangying Cai, Bertram Bengsch, Jonathan B. Johnnidis, Shin Foong Ngiow, Dario A. A. Vignali, Michael A. Paley, Yuki Muroyama, Sasikanth Manne, Arlene H. Sharpe, Shufei Song, Christelle Harly, Jason M. Schenkel, John Attanasio, Jesse M. Platt, Zeyu Chen, Allison R. Greenplate, Avinash Bhandoola, Steven L. Reiner, F. Bradley Johnson, Mohamed S. Abdel-Hakeem, Kito Nzingha, Jean Christophe Beltra, Makoto Kurachi, Mohammed Alkhatim A. Ali, Josephine R. Giles, Vesselin T. Tomov, E. John Wherry, University of Pennsylvania [Philadelphia], Washington University in Saint Louis (WUSTL), Massachusetts General Hospital [Boston], Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), Massachusetts Institute of Technology (MIT), Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications (CRCINA-ÉQUIPE 1), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), LabEX IGO Immunothérapie Grand Ouest, Freiburg University Medical Center, Centre for Biological Signaling Studies [Freiburg] (BIOSS), University of Freiburg [Freiburg], Kanazawa University (KU), University of Pittsburgh School of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE), UPMC Hillman Cancer Center [Pittsburgh, PA, États-Unis], Columbia University [New York], University of Pennsylvania, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Nantes Université (Nantes Univ), Universitäts Klinikum Freiburg = University Medical Center Freiburg (Uniklinik), and Bernardo, Elizabeth
- Subjects
0301 basic medicine ,Effector ,DNA damage ,Chemistry ,T cell ,Lymphocyte ,Immunology ,Eomesodermin ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,General Medicine ,Cell biology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,medicine ,Cytotoxic T cell ,CD5 ,CD8 ,030215 immunology - Abstract
International audience; The developmental origins of memory T cells remain incompletely understood. During the expansion phase of acute viral infection, we identified a distinct subset of virus-specific CD8 + T cells that possessed distinct characteristics including expression of CD62L, T cell factor 1 (TCF-1), and Eomesodermin; relative quiescence; expression of activation markers; and features of limited effector differentiation. These cells were a quantitatively minor subpopulation of the TCF-1 + pool and exhibited self-renewal, heightened DNA damage surveillance activity, and preferential long-term recall capacity. Despite features of memory and somewhat restrained proliferation during the expansion phase, this subset displayed evidence of stronger TCR signaling than other responding CD8 + T cells, coupled with elevated expression of multiple inhibitory receptors including programmed cell death 1 (PD-1), lymphocyte activating gene 3 (LAG-3), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), CD5, and CD160. Genetic ablation of PD-1 and LAG-3 compromised the formation of this CD62L hi TCF-1 + subset and subsequent CD8 + T cell memory. Although central memory phenotype CD8 + T cells were formed in the absence of these cells, subsequent memory CD8 + T cell recall responses were compromised. Together, these results identify an impor tant link between genome integrity maintenance and CD8 + T cell memory. Moreover, the data indicate a role for inhibitory receptors in preserving key memory CD8 + T cell precursors during initial activation and differentiation. Identification of this rare subpopulation within the memory CD8 + T cell precursor pool may help reconcile models of the developmental origin of long-term CD8 + T cell memory.
- Published
- 2021
- Full Text
- View/download PDF